---
figid: PMC10468808__etm-26-04-12164-g01
figtitle: Activation of NFKB and MAPK signaling pathways regulates the expression
  of catabolic factors
organisms:
- NA
organisms_ner:
- Caenorhabditis elegans
- Homo sapiens
pmcid: PMC10468808
filename: PMC10468808__etm-26-04-12164-g01.jpg
figlink: /pmc/articles/PMC10468808/figure/F2
number: F2
caption: Activation of NF-κB and MAPK signaling pathways regulates the expression
  of catabolic factors. External signals activate TRAF2/TRAF6, and induce the phosphorylation
  of MAPK (JNK, p38 MAPK and ERK1/2) by mediating TAK1. The phosphorylation of IKKα/IKKβ
  is induced by TAK1 and external signals. The IKK-induced phosphorylation of IκBα
  may lead to its degradation and the release of p65/p50, which enter the nucleus
  for the transcriptional regulation of target genes, including IL-1β, TNFα, COX-2,
  iNOS, MMPs and ADAMTSs. Ginsenosides may inhibit NF-κB and MAPK signaling pathways,
  and suppress inflammatory responses. TRAF, TNF receptor-associated factor; TAK,
  transforming growth factor-β activated kinase; IKK, inhibitor of IκB kinase; COX,
  cyclooxygenase; iNOS, inducible isoform of nitric oxide synthase; ADAMTSs, A disintegrin
  and metalloproteinase with thrombospondin motifs; MEKK, mitogen-activated protein
  kinase kinase kinase 1
papertitle: Protective effects of ginseng and ginsenosides in the development of osteoarthritis
  (Review)
reftext: Jincai Chen, et al. Exp Ther Med. 2023 Oct;26(4).
year: '2023'
doi: 10.3892/etm.2023.12164
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos
keywords: osteoarthritis | ginsenosides | NF-κB | MAPK | extracellular matrix degradation
automl_pathway: 0.9568978
figid_alias: PMC10468808__F2
figtype: Figure
redirect_from: /figures/PMC10468808__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10468808__etm-26-04-12164-g01.html
  '@type': Dataset
  description: Activation of NF-κB and MAPK signaling pathways regulates the expression
    of catabolic factors. External signals activate TRAF2/TRAF6, and induce the phosphorylation
    of MAPK (JNK, p38 MAPK and ERK1/2) by mediating TAK1. The phosphorylation of IKKα/IKKβ
    is induced by TAK1 and external signals. The IKK-induced phosphorylation of IκBα
    may lead to its degradation and the release of p65/p50, which enter the nucleus
    for the transcriptional regulation of target genes, including IL-1β, TNFα, COX-2,
    iNOS, MMPs and ADAMTSs. Ginsenosides may inhibit NF-κB and MAPK signaling pathways,
    and suppress inflammatory responses. TRAF, TNF receptor-associated factor; TAK,
    transforming growth factor-β activated kinase; IKK, inhibitor of IκB kinase; COX,
    cyclooxygenase; iNOS, inducible isoform of nitric oxide synthase; ADAMTSs, A disintegrin
    and metalloproteinase with thrombospondin motifs; MEKK, mitogen-activated protein
    kinase kinase kinase 1
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - mkk-4
  - mek-2
  - mek-1
  - COX2
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - CHUK
  - IKBKG
  - IL1R1
  - TNFRSF1A
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - TRAF2
  - TANK
  - TRAF6
  - MAP3K2
  - MAP3K1
  - MAP3K7
  - NR2C2
  - MAP2K4
  - MAP2K6
  - MAP2K2
  - MAP2K1
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK3
  - PTGS2
  - NOS2
  - ISYNA1
  - TNF
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - IL1A
  - IL1B
  - ROS
---
